Last week, when the CEO of drugmaker Mylan was testifying before Congress, Rep. Jason Chafee of Utah spoke for the American people when he wondered whether the company actually earns only $52 profit per pen when the retail list price is $608 each. The company has now clarified its answer: that $104 per two-pack figure is Mylan’s profit after taxes. Before taxes, the profit is $88 per pen, or $166 per two-pack. [More]
The price of the EpiPen emergency allergy medication soared by 400% to 600% over the last decade, in part due to a lack of competition. In February, the FDA rejected a potential competing injector from Teva Pharmaceuticals, but now the company says it still hopes to get an EpiPen alternative in pharmacies — at some point in the next two years. [More]
One solution that some families have used in response to the soaring cost of Mylan’s EpiPen, an essential product for people with life-threatening allergies, is to order the product from a cheaper pharmacy in Canada instead. While this might appear to be a solid plan, the problem is that “Canadian” pharmacies aren’t always necessarily what they claim to be online. [More]
This morning, drug company Mylan announced that it will soon introduce a lower-cost (but still not cheap) generic version of its popular EpiPen emergency allergy treatment. In response, one senator who has been critical of Mylan’s actions says more must be done to make the life-saving drug available. [More]
Facing criticism from patients, consumer advocates, lawmakers, and physicians about huge price increases on the EpiPen emergency allergy treatment, drugmaker Mylan today announced it will introduce a generic version of the epinephrine auto-injector for half the current sticker price of the name-brand drug. [More]
With the price of emergency allergy treatment EpiPen jumping nearly 600% in less than a decade, bringing the out-of-pocket cost for some patients to $600 for a two-pack, it’s perhaps not surprising that sketchy eBay sellers are claiming to offer the prescription medication at a discount, even though it’s against eBay policy, illegal, and just a really, really, really awful idea. [More]
If you or someone you know uses Primatene or any other over-the-counter epinephrine inhaler for asthma, the clock is officially ticking before they disappear off store shelves. The Food and Drug Administration announced today that, in an effort to cut down on products using ozone-depleting chlorofluorocarbons, these inhalers will no longer be available after Dec. 31.